ZJYL

Jin Medical International Ltd. ZJYL

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $23.5M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$20.69M

Quarter to Sep 30

Net income

$1.19M

Quarter to Sep 30

Free cash flow

$-3.73M

Quarter to Sep 30

Operating margin

2.9%

Quarter to Sep 30

Top Institutional Holders

as of Q4 2025
$88.6K total
CITADEL ADVISORS LLC
$25.9KNew
GEODE CAPITAL MANAGEMENT, LLC
$23.4KNew
JANE STREET GROUP, LLC
$11.2KNew
RENAISSANCE TECHNOLOGIES LLC
$8.8KNew
OSAIC HOLDINGS, INC.
$7.0KNew
XTX Topco Ltd
$6.3KNew
TWO SIGMA SECURITIES, LLC
$4.8KNew
UBS Group AG
$987New
Bell Investment Advisors, Inc
$34New
MORGAN STANLEY
$22New
See all 10 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Debt/Equity

FY 2025
EDGAR

Loading ratio trend…

ZJYL key financials by period

Reported revenue, net income and operating margin by fiscal year, from Jin Medical International Ltd.'s annual filings on SEC EDGAR.

Jin Medical International Ltd. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$20.7M$1.2M2.9%
FY 2024$23.5M$3.7M15.5%
FY 2023$19.8M$2.9M14.5%
FY 2022$19.2M$2.7M11.1%
FY 2021$20.8M$2.6M12.7%
Source: ZJYL filings on SEC EDGAR →

About Jin Medical International Ltd. (ZJYL): stock profile, AI score and financials

Jin Medical International Ltd. (ZJYL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ZJYL is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $23.5m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2025), Jin Medical International Ltd. reports quarterly revenue of $20.7M, net income of $1.2M, an operating margin of 2.9%. Top institutional holders of ZJYL by reported 13-F value include CITADEL ADVISORS, GEODE CAPITAL MANAGEMENT, JANE STREET GROUP, based on the most recent SEC filings. ZJYL trades on the Nasdaq exchange and files with the SEC under CIK 1837821. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ZJYL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Jin Medical International Ltd. directly from SEC EDGAR.

SEC EDGAR: CIK 1837821 →